Foley Hoag Represents Daewoong in $336 Million Deal with CS Pharma
February 08, 2023
Foley Hoag LLP represented South Korea's Daewoong Pharmaceutical (“Daewoong”) in securing an exclusive licensing agreement with CS Pharmaceuticals, a UK based multinational company focused on the development and commercialization of rare disease and ophthalmology products in China, for a first-in-class PRS inhibitor ‘Bersiporocin’ in Greater China region, including mainland China, Hong Kong, Taiwan, and Macau.
Daewoong is developing the world's first-in-class candidate substance against idiopathic pulmonary fibrosis, 'Bersiporocin'. Under the agreement, Daewoong will grant CS Pharmaceuticals with exclusive rights for development and commercialization of Bersiporocin for the treatment of idiopathic pulmonary fibrosis and other respiratory indications.
Foley Hoag attorneys Hemmie Chang, David Halstead, John Harre, Sumantha Sedor, Anna Cardoso and Nicola Lemay represented Daewoong in the deal.
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
